News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
493,810 Results
Type
Article (34074)
Company Profile (66)
Press Release (459662)
Multimedia
Podcasts (98)
Webinars (10)
Section
Business (133112)
Career Advice (2530)
Deals (26705)
Drug Delivery (101)
Drug Development (63520)
Employer Resources (145)
FDA (11676)
Job Trends (10858)
News (237886)
Policy (23172)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (1921)
Academic (1)
Accelerated approval (26)
Adcomms (21)
Allergies (120)
Alliances (33807)
ALS (161)
Alzheimer's disease (1489)
Antibody-drug conjugate (ADC) (279)
Approvals (11894)
Artificial intelligence (428)
Autoimmune disease (123)
Automation (28)
Bankruptcy (238)
Best Places to Work (8690)
BIOSECURE Act (19)
Biosimilars (145)
Biotechnology (53)
Bladder cancer (145)
Brain cancer (47)
Breast cancer (567)
Cancer (4168)
Cardiovascular disease (346)
Career advice (2109)
Career pathing (39)
CAR-T (228)
CDC (47)
Cell therapy (622)
Cervical cancer (33)
Clinical research (54935)
Collaboration (1419)
Company closure (2)
Compensation (430)
Complete response letters (55)
COVID-19 (2332)
CRISPR (68)
C-suite (531)
Cystic fibrosis (122)
Data (5434)
Decentralized trials (2)
Denatured (17)
Depression (132)
Diabetes (421)
Diagnostics (5361)
Digital health (34)
Diversity (7)
Diversity, equity & inclusion (31)
Drug discovery (203)
Drug pricing (161)
Drug shortages (27)
Duchenne muscular dystrophy (216)
Earnings (63413)
Editorial (59)
Employer branding (19)
Employer resources (126)
Events (76936)
Executive appointments (621)
FDA (14330)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (22)
Funding (1057)
Gene editing (166)
Generative AI (39)
Gene therapy (511)
GLP-1 (867)
Government (3770)
Grass and pollen (4)
Guidances (378)
Healthcare (13081)
HIV (46)
Huntington's disease (41)
IgA nephropathy (81)
Immunology and inflammation (239)
Immuno-oncology (59)
Indications (90)
Infectious disease (2560)
Inflammatory bowel disease (161)
Inflation Reduction Act (10)
Influenza (93)
Intellectual property (224)
Interviews (485)
IPO (13702)
IRA (40)
Job creations (2466)
Job search strategy (1744)
JPM (59)
Kidney cancer (16)
Labor market (71)
Layoffs (417)
Leadership (38)
Legal (4647)
Liver cancer (83)
Longevity (10)
Lung cancer (566)
Lymphoma (336)
Machine learning (33)
Management (54)
Manufacturing (637)
MASH (144)
Medical device (9879)
Medtech (9912)
Mergers & acquisitions (13973)
Metabolic disorders (1126)
Multiple sclerosis (144)
NASH (13)
Neurodegenerative disease (307)
Neuropsychiatric disorders (84)
Neuroscience (2592)
Neurotech (1)
NextGen: Class of 2026 (4137)
Non-profit (2700)
Now hiring (40)
Obesity (538)
Opinion (295)
Ovarian cancer (147)
Pain (169)
Pancreatic cancer (196)
Parkinson's disease (242)
Partnered (26)
Patents (434)
Patient recruitment (380)
Peanut (45)
People (33621)
Pharmaceutical (14)
Pharmacy benefit managers (22)
Phase 1 (16900)
Phase 2 (24478)
Phase 3 (18966)
Pipeline (4618)
Policy (250)
Postmarket research (1646)
Preclinical (6397)
Press Release (56)
Prostate cancer (206)
Psychedelics (39)
Radiopharmaceuticals (225)
Rare diseases (757)
Real estate (3688)
Recruiting (60)
Regulatory (18437)
Reports (39)
Research institute (1766)
Resumes & cover letters (428)
Rett syndrome (23)
RNA editing (13)
RSV (65)
Schizophrenia (135)
Series A (157)
Series B (119)
Service/supplier (4)
Sickle cell disease (82)
Special edition (22)
Spinal muscular atrophy (148)
Sponsored (34)
Startups (2304)
State (1)
Stomach cancer (17)
Supply chain (84)
Tariffs (74)
The Weekly (80)
Vaccines (901)
Venture capital (81)
Weight loss (368)
Women's health (62)
Worklife (21)
Date
Today (12)
Last 7 days (450)
Last 30 days (1562)
Last 365 days (24548)
2026 (2216)
2025 (24898)
2024 (28470)
2023 (32152)
2022 (40768)
2021 (42822)
2020 (40816)
2019 (32111)
2018 (24261)
2017 (24739)
2016 (22531)
2015 (26581)
2014 (19035)
2013 (22338)
2012 (15802)
2011 (16368)
2010 (14474)
Location
Africa (685)
Alabama (76)
Alaska (5)
Arizona (155)
Arkansas (6)
Asia (29974)
Australia (5028)
California (8875)
Canada (2719)
China (905)
Colorado (370)
Connecticut (387)
Delaware (268)
Europe (67380)
Florida (1346)
Georgia (277)
Hawaii (2)
Idaho (30)
Illinois (611)
India (50)
Indiana (428)
Iowa (15)
Japan (363)
Kansas (92)
Kentucky (16)
Louisiana (20)
Maine (76)
Maryland (1113)
Massachusetts (6154)
Michigan (245)
Minnesota (451)
Mississippi (4)
Missouri (102)
Montana (27)
Nebraska (16)
Nevada (97)
New Hampshire (60)
New Jersey (2543)
New Mexico (26)
New York (2440)
North Carolina (1047)
North Dakota (3)
Northern California (4341)
Ohio (241)
Oklahoma (15)
Oregon (36)
Pennsylvania (1766)
Puerto Rico (21)
Rhode Island (29)
South America (889)
South Carolina (54)
Southern California (3485)
Tennessee (119)
Texas (1404)
United States (31272)
Utah (273)
Vermont (1)
Virginia (200)
Washington D.C. (63)
Washington State (739)
West Virginia (3)
Wisconsin (61)
Wyoming (2)
493,810 Results for "biom up".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Orchestra BioMed to Receive Up to $21 Million in Proceeds from Acquisition of Vivasure by Haemonetics
January 13, 2026
·
8 min read
Press Releases
Harbour BioMed Announces Positive Profit Alert for 2025 Annual Results
February 4, 2026
·
3 min read
Press Releases
Harbour BioMed Acquires Common Stock in Spruce Biosciences, Deepening Strategic Collaboration
January 19, 2026
·
2 min read
Press Releases
Mainz Biomed to Present Results of Pancreatic Cancer Verification Study at AACR 2026 Annual Meeting
January 15, 2026
·
3 min read
Press Releases
Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences - November 11, 2025
November 11, 2025
·
2 min read
Press Releases
Advanced Biomed Inc. Announces Disposal of its Hong Kong Subsidiary
December 30, 2025
·
3 min read
Press Releases
Orchestra BioMed to Host Business Update Call on November 12, 2025
November 4, 2025
·
2 min read
Press Releases
BioMed X Launches XBridge Pilot to Facilitate Industry-Academic Research Collaborations
January 13, 2026
·
1 min read
Mergers & acquisitions
GSK Picks Up RAPT for $2.2B as Miels Makes First Move as CEO
The star of the acquisition, anti-IgE antibody ozureprubart, is being tested as a prophylactic treatment for food allergies, potentially setting up a competition for GSK with Roche’s Xolair.
January 20, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Orchestra BioMed Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates
November 10, 2025
·
14 min read
1 of 49,381
Next
